TME Alteration in HER2 Positive Breast Cancer

Recruiting

• Conditions: Breast Cancer; HER2-positive Breast Cancer; Chemotherapy Effect

• Registration Number: NCT06533670
• Lead Sponsor: Seoul National University Hospital

Brief Summary

Evaluate for changes in the tumor microenvironment before/during neoadjuvant chemotherapy and after treatment in patients diagnosed with HER2-positive advanced breast cancer and receiving neoadjuvant cancer therapy and surgery for curative purposes.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-07
• Study Start: 2024-07-19
• Study First Submitted: 2024-07-30
• Study First Submitted QC: 2024-07-30
• Last Update Submitted: 2024-07-30
• Study First Posted: 2024-08-01
• Last Update Posted: 2024-08-01
• Primary Completion: 2026-07-19
• Study Completion: 2026-07-19

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
tumor microenvironment alteration	6 months	tumor microenvironment changes during neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer.

Trial Locations

Locations (1)

Seoul National University Hospital; 🇰🇷 Seoul, Korea, Republic of